• 1. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 4. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 5. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazole carboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Pyrazole carboxylic acids and derivatives

Methyl 1-(4-ethoxy-4-oxobutyl)-1H-pyrazole-3-carboxylate (CAS No. 1172806-62-0): A Comprehensive Overview

Methyl 1-(4-ethoxy-4-oxobutyl)-1H-pyrazole-3-carboxylate (CAS No. 1172806-62-0) is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and biochemistry. This compound, characterized by its unique structural and functional attributes, plays a pivotal role in various research applications, particularly in the development of novel therapeutic agents and biochemical probes.

The molecular structure of Methyl 1-(4-ethoxy-4-oxobutyl)-1H-pyrazole-3-carboxylate consists of a pyrazole core substituted with an ethoxybutyl group at the 1-position and a carboxylate moiety at the 3-position. This configuration imparts distinct chemical properties that make it a valuable intermediate in synthetic chemistry. The presence of the ethoxybutyl group enhances the compound's solubility and reactivity, facilitating its use in various chemical transformations.

In recent years, Methyl 1-(4-ethoxy-4-oxobutyl)-1H-pyrazole-3-carboxylate has been extensively studied for its potential applications in drug discovery. The pyrazole scaffold is well-documented for its biological activity, particularly in the inhibition of enzymes and receptors involved in inflammatory and infectious diseases. Researchers have leveraged this scaffold to design molecules with enhanced pharmacological profiles.

One of the most notable applications of Methyl 1-(4-ethoxy-4-oxobutyl)-1H-pyrazole-3-carboxylate is in the synthesis of protease inhibitors. Proteases are enzymes that play a crucial role in various physiological processes, including signal transduction and pathogen survival. By targeting these enzymes, researchers aim to develop treatments for conditions such as cancer, autoimmune diseases, and viral infections. The compound's structural features make it an ideal candidate for modulating protease activity, thereby offering a promising avenue for therapeutic intervention.

Furthermore, Methyl 1-(4-ethoxy-4-oxobutyl)-1H-pyrazole-3-carboxylate has been explored as a key intermediate in the synthesis of kinase inhibitors. Kinases are another class of enzymes that are frequently implicated in disease pathways. Inhibiting specific kinases can lead to significant therapeutic benefits, making this compound a valuable tool in medicinal chemistry research.

The compound's versatility extends to its utility as a biochemical probe. By using Methyl 1-(4-ethoxy-4-oxobutyl)-1H-pyrazole-3-carboxylate, researchers can investigate the interactions between enzymes and substrates, providing insights into enzyme mechanisms and potential drug targets. This information is crucial for designing more effective drugs with improved efficacy and reduced side effects.

Recent advancements in computational chemistry have further enhanced the utility of Methyl 1-(4-ethoxy-4-oxobutyl)-1H-pyrazole-3-carboxylate. Molecular modeling studies have revealed its binding interactions with various biological targets, providing a detailed understanding of its pharmacophore. These studies have guided the optimization of synthetic routes to improve yield and purity, ensuring that researchers have access to high-quality material for their experiments.

The synthesis of Methyl 1-(4-ethoxy-4-oxobutyl)-1H-pyrazole-3-carboxylate involves multi-step organic reactions that highlight the compound's synthetic challenges and opportunities. Advanced synthetic methodologies have been employed to achieve high regioselectivity and stereoselectivity, ensuring that the final product meets the stringent requirements of pharmaceutical applications.

In conclusion, Methyl 1-(4-ethoxy-4-oxybutyl)-1H-pyrazole-3-carboxylate (CAS No. 1172806-62-0) is a multifaceted compound with significant potential in pharmaceutical research. Its unique structural features make it an invaluable intermediate in drug discovery, particularly for developing protease and kinase inhibitors. As research continues to uncover new applications for this compound, its importance in advancing therapeutic strategies is likely to grow even further.

• 1002535-19-4(1-Cyclopentyl-1 H -pyrazole-3-carboxylic acid ethyl ester)
• 1171386-33-6(methyl 1-(4-ethoxy-4-oxobutyl)-1H-pyrazole-5-carboxylate)
• 1172405-66-1(methyl 1-(1-ethoxy-1-oxobutan-2-yl)-1H-pyrazole-3-carboxylate)
• 1007503-15-2(Ethyl 1-ethyl-1H-pyrazole-3-carboxylate)
• 1171714-36-5(methyl 1-(4-ethoxy-4-oxobutyl)-5-methyl-1H-pyrazole-3-carboxylate)
• 60056-63-5(methyl 1-butyl-1H-pyrazole-3-carboxylate)
• 330824-86-7(1H-Pyrazole-3-carboxylic acid, 1,1'-(1,4-butanediyl)bis[5-methyl-,dimethyl ester)
• 1171364-51-4(ethyl 4-(3-methyl-1H-pyrazol-1-yl)butanoate)
• 1171509-23-1(methyl 1-(3-methoxy-2-methyl-3-oxopropyl)-1H-pyrazole-3-carboxylate)
• 1171028-49-1(methyl 1-propyl-1H-pyrazole-3-carboxylate)